Endometrial Cancer Treatment in Cuba
Comprehensive endometrial cancer evaluation and treatment programs through Cuba's international healthcare system, including immunotherapy approaches.
Overview
Endometrial cancer, often called uterine cancer, begins in the lining of the uterus (the endometrium). It is the most common gynecologic cancer in developed countries and is usually found at an early stage because it causes noticeable symptoms — particularly abnormal vaginal bleeding. The most common type is endometrioid adenocarcinoma (a cancer that begins in the glandular cells of the uterine lining). When found early, endometrial cancer has a good outlook. Cuba's oncology centers provide comprehensive evaluation and treatment programs for international patients with endometrial cancer.
Symptoms
- Abnormal vaginal bleeding (between periods, after menopause, or unusually heavy periods)
- Watery or blood-tinged vaginal discharge
- Pelvic pain or pressure
- Pain during intercourse
- Unexplained weight loss
- Difficulty or pain when urinating
- A mass or lump in the pelvic area
Risk Factors
- Exposure to estrogen without sufficient progesterone (estrogen-only therapy)
- Obesity (fat tissue produces estrogen)
- Polycystic ovary syndrome (PCOS)
- Never having been pregnant
- Early menstruation or late menopause
- Age over 50 (most common after menopause)
- Family history of endometrial or colorectal cancer (Lynch syndrome)
- Tamoxifen use for breast cancer treatment
- Diabetes and metabolic syndrome
Diagnosis
Diagnosis involves pelvic examination, transvaginal ultrasound to measure endometrial thickness, and endometrial biopsy or dilation and curettage (D&C) to obtain tissue for pathology. Hysteroscopy allows direct visualization of the uterine cavity. Imaging studies including CT scan and MRI are used for staging. Molecular testing may be performed to identify specific genetic characteristics. Cuban oncology centers utilize advanced diagnostic imaging and molecular testing for precise evaluation.
Disease Stages
Endometrial cancer staging follows the FIGO system. Stage I: Cancer is confined to the uterus. Stage II: Cancer has spread to the cervix but not beyond the uterus. Stage III: Cancer has spread to the vagina, pelvic lymph nodes, or nearby tissues. Stage IV: Cancer has spread to the bladder, rectum, or distant organs. Treatment approaches vary significantly by stage and molecular profile.
Standard Treatment Options
surgery
Surgical treatment is the primary approach for endometrial cancer. Total hysterectomy with bilateral salpingo-oophorectomy (removal of uterus, fallopian tubes, and ovaries) is the standard procedure. Lymph node dissection may be performed for staging. Surgery may be curative for early-stage disease.
chemotherapy
Chemotherapy may be used after surgery for high-risk or advanced-stage endometrial cancer. Common regimens include carboplatin with paclitaxel. It may also be used for recurrent or metastatic disease.
radiotherapy
Radiation therapy may be used after surgery (adjuvant) to reduce recurrence risk, particularly for intermediate and high-risk cases. Brachytherapy (internal radiation) and external beam radiation may be used. It may also be used for patients who cannot undergo surgery.
targeted
Targeted therapies may be considered for advanced or recurrent endometrial cancer with specific molecular profiles. These include mTOR inhibitors and agents targeting PIK3CA mutations. Molecular testing of the tumor is essential to determine if targeted therapy is appropriate.
immunotherapy
Immunotherapy approaches, including immune checkpoint inhibitors (pembrolizumab), may be considered for advanced or recurrent endometrial cancers with specific molecular profiles (e.g., MSI-H, dMMR). Cuba's biotechnology research includes investigation of immunotherapeutic approaches that may be considered for eligible international patients.
supportive
Supportive care includes management of treatment side effects, pain management, nutritional support, psychological support, management of lymphedema after lymph node dissection, and palliative care to improve quality of life.
Potential Treatment Approaches in Cuba
Cuba's approach to endometrial cancer involves comprehensive evaluation by a multidisciplinary team including gynecologic oncologists, medical oncologists, and radiation oncologists. For international patients, the process begins with a thorough review of medical records, including biopsy reports, pathology, and imaging studies. The oncology team evaluates each case individually to determine the most appropriate treatment strategy, considering the cancer's stage, molecular profile, and the patient's overall health.
Explore Cuba's Treatment for This Condition
Cuba offers specialized treatment programs for this condition. Learn more about the therapy, eligibility, and how to request a medical evaluation.
Who May Be Eligible
Eligibility for endometrial cancer treatment in Cuba is determined through medical review of the patient's diagnosis, staging, molecular profile, prior treatments, and overall health status. Each case is evaluated individually by the Cuban oncology team. Patients must provide complete medical records for review before a treatment plan can be proposed.
Required Medical Documents
- Histopathology / biopsy report confirming diagnosis
- Transvaginal ultrasound report
- MRI of the pelvis and CT scan of abdomen and chest
- Molecular testing results (MSI, MMR status) if available
- Oncologist's/gynecologist's treatment summary
- Current medication list
- Recent general blood panel (CBC, liver and kidney function)
How to Request a Medical Evaluation
Submit your medical records for review by our oncology team. If treatment may be appropriate for your case, a personalized plan will be developed. You only travel to Cuba after the medical team confirms eligibility.
Frequently Asked Questions
Can international patients receive endometrial cancer treatment in Cuba?
Yes. International patients may be evaluated for endometrial cancer treatment through SMC Salud. The process begins with a medical review of your records. If the oncology team determines that treatment may be appropriate, a personalized plan is developed.
What treatment options are available for endometrial cancer in Cuba?
Treatment options may include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy approaches. The specific options depend on the cancer's stage, molecular profile, and the patient's overall health. The oncology team determines suitability after reviewing your complete medical records.
Is endometrial cancer curable in Cuba?
No treatment can guarantee a cure for endometrial cancer. For early-stage disease, surgery may offer the best chance for prolonged survival. For advanced cases, treatment focuses on controlling the disease and improving quality of life. Our oncology team provides realistic expectations based on each patient's specific situation.
How do I request a medical evaluation for endometrial cancer?
You can request a medical evaluation by submitting your medical documents through our patient intake form. You will need your biopsy reports, imaging studies, and treatment summary. Our international patient services team will guide you through the process.
Can my medical records be reviewed before I travel?
Yes. Medical record review is a required first step. You submit your documents remotely, and the oncology team reviews them to determine whether treatment may be appropriate. You only travel to Cuba if the team confirms that evaluation or treatment may be offered.
References
- World Health Organization — Endometrial Cancer Fact Sheet.
- American Cancer Society — Endometrial Cancer Treatment Guidelines.
- National Comprehensive Cancer Network (NCCN) — Uterine Neoplasms Guidelines.
Medical Disclaimer
The medical information provided on this page is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Eligibility for any treatment depends on the patient's clinical condition and is determined by the treating medical team.
This content has been medically reviewed by qualified physicians and follows SMC Salud's editorial policy for health information. Medical content is for informational purposes and does not replace professional medical advice.